Korean Translations
Neurology® 2015; Vol. 85
Statin treatment reduces the risk of poststroke seizures, Guo et al. 85(8):701-707.
Kidney function and microstructural integrity of brain white matter, Sedaghat et al. 85(2):154-161.
The preclinical stage of spinocerebellar ataxias, Maas et al. 85(1):96-103.
Neurology® 2014; Vol. 83
Neurology® 2014; Vol. 82
Anti-agrin autoantibodies in myasthenia gravis, Gasperi et al. 82(22):1976-1983.
Migraine trait symptoms in migraine with and without aura, Jürgens et al. 82(16):1416-1424.
Prevalence of idiopathic normal-pressure hydrocephalus, Jaraj et al. 82(16):1449-1454.
Influence of seizures on stroke outcomes: A large multicenter study, Huang et al. 82(9):768-776.
Ketogenic diet for adults in super-refractory status epilepticus, Thakur et al. 82(8):665-670.
Neurology® 2013; Vol. 81
Migraine prevalence, socioeconomic status, and social causation, Stewart et al. 81(11):948-955.
MRI-identified pathology in adults with new-onset seizures, Hakami et al. 81(10):920-927.
Traumatic brain injury may be an independent risk factor for stroke, Burke et al. 81(1):33-39.
Prospective study of restless legs syndrome and mortality among men, Li et al. 81(1):52-59.
Neurology® 2013; Vol. 80
Mortality in Guillain-Barré syndrome, van den Berg et al. 80(18):1650-1654.
Depression in epilepsy: A systematic review and meta-analysis, Fiest et al. 80(6):590-599.
The spectrum of nonmotor symptoms in early Parkinson disease, Khoo et al. 80(3):276-281.
Neurology® 2012; Vol. 79
Dexamethasone and long-term survival in bacterial meningitis, Fritz et al. 79(22):2177-2179.
Migraine headache is present in the aura phase: A prospective study, Hansen et al. 79(20):2044-2049.
Parkinson disease and driving: An evidence-based review, Crizzle et al. 79(20):2067-2074.
Poststroke fatigue following minor infarcts: A prospective study, Radman et al. 79(14):1422-1427.
New ischemic lesions coexisting with acute intracerebral hemorrhage, Kang et al. 79(9):848-855.
Neurology® 2012; Vol. 78
Proteinuria and clinical outcomes after ischemic stroke, Kumai et al. 78(24):1909-1915.
Comparative safety of antiepileptic drugs during pregnancy, Hernández-Díaz et al. 78(21):1692-1699.
Patterns of treatment response in newly diagnosed epilepsy, Brodie et al. 78(20):1548-1554.
Habitual intake of dietary flavonoids and risk of Parkinson disease, Gao et al. 78(15):1138-1145.
Lamotrigine and aseptic meningitis, Simms et al. 78(12):921-927.
SMN1 gene duplications are associated with sporadic ALS, Blauw et al. 78(11):776-780.
Long-lasting treatment effect of rituximab in MuSK myasthenia, Díaz-Manera et al. 78(3):189-193.
Neurology® 2008; Vol. 71
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial, Sorenson et al. 71(22):1770-1775.
Excessive acute migraine medication use and migraine progression, Bigal and Lipton 71(22):1821-1828.
Cross-sensitivity of skin rashes with antiepileptic drug use, Hirsch et al. 71(19):1527-1534.
Treatment of ocular symptoms in myasthenia gravis, Bhanushali at al. 71(17):1335-1341.